| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |